Last10K.com

Cactus Ventures, Inc. (ATNM) SEC Filing 10-K Annual report for the fiscal year ending Wednesday, December 31, 2008

Actinium Pharmaceuticals, Inc.

CIK: 1388320 Ticker: ATNM

View differences made from one year to another to evaluate Actinium Pharmaceuticals, Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 10-K Annual Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Actinium Pharmaceuticals, Inc..

Continue

Assess how Actinium Pharmaceuticals, Inc.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Actinium Pharmaceuticals, Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2009 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools

Material Contracts, Statements, Certifications & more

Actinium Pharmaceuticals, Inc. provided additional information to their SEC Filing as exhibits

Ticker: ATNM
CIK: 1388320
Form Type: 10-K Annual Report
Accession Number: 0001078782-09-000257
Submitted to the SEC: Fri Feb 20 2009 3:44:06 PM EST
Accepted by the SEC: Fri Feb 20 2009
Period: Wednesday, December 31, 2008
Industry: Pharmaceutical Preparations

External Resources:
Stock Quote
Social Media

Bookmark the Permalink:
https://last10k.com/sec-filings/atnm/0001078782-09-000257.htm